Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Decrease the Frequency of Inappropriate Intravenous Lines in Internal Medicine (PERMI)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stephane Mouly, MD PhD, Hopital Lariboisière
ClinicalTrials.gov Identifier:
NCT01633307
First received: June 19, 2012
Last updated: July 3, 2012
Last verified: June 2012

June 19, 2012
July 3, 2012
January 2007
April 2007   (final data collection date for primary outcome measure)
frequency of inappropriate intravenous infusion in internal medicine department [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01633307 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Decrease the Frequency of Inappropriate Intravenous Lines in Internal Medicine
Effect of a Nationwide Teaching Program on the Frequency of Inappropriate Intravenous Lines in Internal Medicine: A Randomized Controlled Trial

Aim: to determine whether a nationwide teaching program delivered to medical doctors can decrease the use of inappropriate intravenous lines in internal medicine

Nationwide multicentre randomized prospective controlled trial enrolling 59 french internal medicine departments. During the first study visit, we collected data of patients with intravenous infusions from each participating centre in order to determine the number and frequency of inappropriate intravenous lines. Using a computerized randomization process (on a 1:1 basis), the participating centres were randomized; Half centres (interventional group) received an educational program consisting of educational material and two educational sessions; the other half did not receive the educational program (control group). The educational program provided medical doctors with posters and slides containing information on valid indications for the prescription and use of intravenous infusions (inability to drink or eat, malabsorption, medication only available intravenously with no oral equivalent). Based on a previous pilot study, we assumed that the the frequency of inappropriate intravenous lines with be approximately 20% at baseline and hypothesize that the nationwide teaching program will decrease this frequency by 50%.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Acute Medical Patients Hospitalized in Internal Medicine
Other: Education
Teaching program
  • Experimental: Experimental
    Intervention (Teaching program)
    Intervention: Other: Education
  • No Intervention: Control group
    No teaching program
Champion K, Mouly S, Lloret-Linares C, Lopes A, Vicaut E, Bergmann JF; PERMI Investigators Committee. Optimizing the use of intravenous therapy in internal medicine. Am J Med. 2013 Oct;126(10):925.e1-9. doi: 10.1016/j.amjmed.2013.03.028. Epub 2013 Aug 3.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
59
May 2007
April 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Internal medicine department
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01633307
PERMI
Yes
Stephane Mouly, MD PhD, Hopital Lariboisière
Hopital Lariboisière
Not Provided
Principal Investigator: stephane J mouly, MD PhD Hopital Lariboisiere
Hopital Lariboisière
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP